He Xuemei, Zheng Yuanru, Tian Chunyang, Wen Ting, Yang Tangjia, Yu Jingtao, Fang Xiaochuan, Fan Chunlin, Liu Junshan, Yu Linzhong
Third Level Research Laboratory of State Administration of Traditional Chinese Medicine, School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, PR China; Guangdong Provincial Key Laboratory of Chinese Medicine Pharmaceutics, Guangzhou 510515, PR China.
College of Pharmacy, Jinan University, Guangzhou 510632, PR China.
Phytomedicine. 2023 Feb;110:154650. doi: 10.1016/j.phymed.2023.154650. Epub 2023 Jan 5.
Dengue caused by dengue virus (DENV) spreads rapidly around the world. However, there are no worldwide licensed vaccines or specific antivirals to combat DENV infection. Quassinoids are the most characteristic components of Eurycoma longifolia, which have been reported to display a variety of biological activities. However, whether quassinoids exert anti-DENV activities remains unknown.
To test the quassinoids of E. longifolia for their activity against DENV and to clarify the potential mechanisms.
The quassinoids from E. longifolia were isolated by chromatography techniques, and their chemical structures were elucidated by spectroscopic analysis. The anti-DENV activities of quassinoids on baby hamster kidney cells BHK-21 were determined by lactate dehydrogenase (LDH) assay. The synthesis of progeny virus was measured by plaque assay. The expression levels of envelope protein (E) and non-structural protein 1 (NS1) were evaluated by qRT-PCR, Western blot and immunofluorescence assays. Molecular docking was used to screen the potential targets of the most active quassinoid against DENV-2, and surface plasmon resonance analysis was employed to confirm the direct binding between the most active quassinoid and potential target.
Twenty-four quassinoids, including three new quassinoids (1 - 3), were isolated from the ethanol extract of E. longifolia. Quassinoids 4, 5, 9, 11, 12, 15, 16, 17, 19 and 20 significantly reduced the LDH release at the stages of viral binding and entry or intracellular replication. Among them, 19 (6α-hydroxyeurycomalactone, 6α-HEL) exhibited the best anti-DENV-2 activities with an EC value of 0.39 ± 0.02 μM. Further experiments suggested that 6α-HEL remarkably inhibited progeny virus synthesis and mRNA and protein expression levels of E and NS1 of DENV-2. Time-of-drug-addition assay suggested that 6α-HEL inhibited intracellular replication of DENV-2 at an early stage. Moreover, 6α-HEL was shown to interact with NS5-RdRp domain at a binding affinity of -8.15 kcal/mol. SPR assay further verified 6α-HEL bound to RdRp protein with an equilibrium dissociation constant of 1.49 × 10 M.
Ten quassinoids from E. longifolia showed anti-DENV activities at processes of virus binding and entry or intracellular replication. The most active quassinoid 6α-HEL exerts the anti-DENV-2 activities at intracellular replication stage by directly targeting the NS5-RdRp protein. These results suggest that 6α-HEL could be a promising candidate for the treatment of DENV-2 infection.
登革病毒(DENV)引起的登革热在全球迅速传播。然而,目前尚无全球获批的疫苗或特异性抗病毒药物来对抗DENV感染。苦木素类化合物是长叶淫羊藿最具特征性的成分,据报道具有多种生物活性。然而,苦木素类化合物是否具有抗DENV活性尚不清楚。
测试长叶淫羊藿中的苦木素类化合物对DENV的活性,并阐明其潜在机制。
采用色谱技术从长叶淫羊藿中分离苦木素类化合物,通过光谱分析阐明其化学结构。采用乳酸脱氢酶(LDH)法测定苦木素类化合物对幼仓鼠肾细胞BHK - 21的抗DENV活性。通过蚀斑试验测定子代病毒的合成。采用qRT - PCR、蛋白质免疫印迹和免疫荧光试验评估包膜蛋白(E)和非结构蛋白1(NS1)的表达水平。利用分子对接筛选对DENV - 2活性最强的苦木素类化合物的潜在靶点,并采用表面等离子体共振分析证实活性最强的苦木素类化合物与潜在靶点之间的直接结合。
从长叶淫羊藿乙醇提取物中分离得到24种苦木素类化合物,包括3种新的苦木素类化合物(1 - 3)。苦木素类化合物4、5、9、11、12、15、16、17、19和20在病毒结合与进入阶段或细胞内复制阶段显著降低LDH释放。其中,19号化合物(6α - 羟基淫羊藿内酯,6α - HEL)表现出最佳的抗DENV - 2活性,EC值为0.39±0.02 μM。进一步实验表明,6α - HEL显著抑制子代病毒合成以及DENV - 2的E和NS1的mRNA及蛋白表达水平。药物添加时间试验表明,6α - HEL在早期抑制DENV - 2的细胞内复制。此外,6α - HEL与NS5 - RdRp结构域相互作用,结合亲和力为 - 8.15 kcal/mol。表面等离子体共振分析进一步证实6α - HEL与RdRp蛋白结合,平衡解离常数为1.49×10 M。
长叶淫羊藿中的10种苦木素类化合物在病毒结合与进入或细胞内复制过程中表现出抗DENV活性。活性最强的苦木素类化合物6α - HEL通过直接靶向NS5 - RdRp蛋白在细胞内复制阶段发挥抗DENV - 2活性。这些结果表明,6α - HEL可能是治疗DENV - 2感染的有前景的候选药物。